1206776-41-1

Basic information

• Product Name: 4-bromo-2-tert-butyl-6-iodophenol
• Synonyms: 4-bromo-2-tert-butyl-6-iodophenol
• CAS NO: 1206776-41-1
• Molecular Weight: 355.013
• Mol File: 1206776-41-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 4-bromo-2-tert-butyl-6-iodophenol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-bromo-2-tert-butyl-6-iodophenol(1206776-41-1)
• EPA Substance Registry System: 4-bromo-2-tert-butyl-6-iodophenol(1206776-41-1)

Safety Data

• Hazardous Substances Data: 1206776-41-1(Hazardous Substances Data)

Upstream product

• 10323-39-4 4-bromo-2-tert-butylphenol 
• 74-88-4 methyl iodide 

Downstream Products

• 1206776-42-2 C₁₁H₁₄BrIO 
• 1206776-44-4 C₂₁H₂₁BrN₂O₃S 
• 1206776-66-0 N-{3-[3-(2-benzyloxy-pyridin-3-yl)-5-tert-butyl-phenyl]-1-oxo-isochroman-7-yl}-methanesulfonamide 
• 1256488-45-5 N-{3-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydro-pyridin-3-yl)-phenyl]-1-oxo-isochroman-7-yl}-methanesulfonamide 
• 1256488-46-6 N-{3-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydro-pyridin-3-yl)-phenyl]-isochroman-7-yl}-methanesulfonamide 
• 1256488-47-7 N-{3-[3-tert-butyl-2-methoxy-5-(2-oxo-1,2-dihydro-pyridin-3-yl)-phenyl]-1-oxo-1,2-dihydro-isoquinolin-7-yl}-methanesulfonamide 
• 1256488-55-7 N-{3-[3-tert-Butyl-2-methoxy-5-(3-oxo-2,3-dihydro-pyridazin-4-yl)-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 
• 1256488-43-3 N-{3-[3-tert-butyl-2-methoxy-5-(6-methoxy-2-oxo-1,2-dihydro-pyridin-3-yl)-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 
• 1256488-53-5 N-{3-[3-tert-Butyl-5-(2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl)-2-methoxy-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 
• 1256488-40-0 N-{3-[3-tert-butyl-5-(5-fluoro-2-oxo-1,2-dihydro-pyridin-3-yl)-2-methoxy-phenyl]-1-oxo-1H-isochromen-7-yl}-methanesulfonamide 
• 1256488-93-3 C₂₁H₂₂BrNO₅S 
• 1206776-45-5 C₂₁H₂₃BrN₂O₄S 
• 1256488-92-2 C₂₂H₂₄BrNO₅S 
• 1256489-11-8 C₂₆H₂₇N₃O₆S 

Relevant articles and documents

SUBSTITUTED BENZOFURANYL AND BENZOXAZOLYL COMPOUNDS AND USES THEREOF

The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (A) : or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (A), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.

HETEROCYCLIC ANTIVIRAL COMPOUNDS

Compounds having the formula I wherein wherein R1, R2, R3b, R4a, R4b, R4c and as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods